Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study content or page functionality.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check53 days agoChange DetectedResults posting details were added, including dates when results were first posted. The study documents were expanded with links to the protocol and informed consent forms, and the outcome measures were updated to specify RECIST-based endpoints and include multiple drug name synonyms.SummaryDifference5%

- Check68 days agoChange DetectedThe change is a minor version update (from v3.4.1 to v3.4.2) with no impact on study data, eligibility, or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedThe footer revision changed from v3.4.0 to v3.4.1; there is no change to core content such as study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.